Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline.
暂无分享,去创建一个
Y. Ho | J. Jeng | Ying-Jan Wang | Mei‐Chi Chang | Jang-Jaer Lee | Tong-Mei Wang | L. Hahn | Po-Hsuen Lee | B. Chiang | Chiu‐Po Chan
[1] J. Jeng,et al. Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[2] H. Philipsen,et al. Betel chewer's mucosa--a review. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[3] W. Millesi,et al. Oral keratinocytes derived from the peritonsillar mucosa express the proinflammatory cytokine IL-6 without prior stimulation. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[4] N. Mak,et al. Involvement of tumor necrosis factor (TNF-alpha) in arsenic trioxide induced apoptotic cell death of murine myeloid leukemia cells. , 2002, Toxicology letters.
[5] E. Mazzoni,et al. Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines. , 2002, International journal of molecular medicine.
[6] P. Greenberg,et al. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses , 2002, Nature Reviews Cancer.
[7] J. Jeng,et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. , 2002, Free radical biology & medicine.
[8] J. Monson,et al. The role of CD8+ T cells in immune responses to colorectal cancer , 2002, Cancer Immunology, Immunotherapy.
[9] Chau-Jong Wang,et al. Induction of epidermal proliferation and expressions of PKC and NF-kappaB by betel quid extracts in mouse: the role of lime-piper additives in betel quid. , 2002, Chemico-biological interactions.
[10] Y. Ho,et al. Prevention of the areca nut extract-induced unscheduled DNA synthesis of gingival keratinocytes by vitamin C and thiol compounds. , 2002, Oral oncology.
[11] H. Wu,et al. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species , 2002, British journal of pharmacology.
[12] Y. Urade,et al. Regulation of Prostaglandin Endoperoxide Synthase-2 and IL-6 Expression in Mouse Bone Marrow-Derived Mast Cells by Exogenous But Not Endogenous Prostanoids1 , 2002, The Journal of Immunology.
[13] C. J. Chen,et al. Association between Genetic Polymorphism of Tumor Necrosis Factor-a and Risk of Oral Submucous Fibrosis, a Pre-cancerous Condition of Oral Cancer , 2001, Journal of dental research.
[14] M. Hüll,et al. Mechanisms of prostaglandin E2‐induced interleukin‐6 release in astrocytes: possible involvement of EP4‐like receptors, p38 mitogen‐activated protein kinase and protein kinase C , 2001, Journal of neurochemistry.
[15] C. Chiang,et al. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[16] K. Kuwano,et al. Molecular mechanisms of pulmonary fibrosis and current treatment. , 2001, Current molecular medicine.
[17] Y. Ho,et al. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. , 2001, Carcinogenesis.
[18] J. Jeng,et al. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. , 2001, Oral oncology.
[19] K. Chang,et al. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases. , 2001, The Kaohsiung journal of medical sciences.
[20] Yao-Hsu Yang,et al. β2‐agonist exerts differential effects on the development of cord blood T cells but not on peripheral blood T cells , 2001, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[21] K. Gomi,et al. Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism1 , 2000, The Journal of Immunology.
[22] H. Frucht,et al. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. , 2000, Carcinogenesis.
[23] Z Chen,et al. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation? , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Y. Ho,et al. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. , 2000, Carcinogenesis.
[25] T. Hirano,et al. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.
[26] R. Flavell,et al. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. , 2000, Free radical biology & medicine.
[27] A. Hoeflich,et al. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. , 2000, Cancer letters.
[28] S. Meghji,et al. Oral submucous fibrosis patients have altered levels of cytokine production. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[29] R. G. Allen,et al. Oxidative stress and gene regulation. , 2000, Free radical biology & medicine.
[30] K. Iwatsuki,et al. Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes. , 1999, The Journal of investigative dermatology.
[31] W. Kobayashi,et al. Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma , 1999, Japanese journal of cancer research : Gann.
[32] S. Takashiba,et al. Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. , 1999, Journal of periodontal research.
[33] C. Sotiriou,et al. The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. , 1999, Anticancer research.
[34] H. Tsukamoto,et al. Cytokine regulation of hepatic stellate cells in liver fibrosis. , 1999, Alcoholism, clinical and experimental research.
[35] J. Shah,et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.
[36] S. Meghji,et al. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. , 1998, Cytokine.
[37] G. Clayman,et al. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. , 1998, Cancer research.
[38] M. Luster,et al. Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species , 1998, Inflammation Research.
[39] J. Jeng,et al. Cytotoxic and cytostatic effects of arecoline on oral mucosal fibroblasts. , 1997, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.
[40] J. Parsonnet. Molecular mechanisms for inflammation-promoted pathogenesis of cancer--The Sixteenth International Symposium of the Sapporo Cancer Seminar. , 1997, Cancer research.
[41] R. Oyasu,et al. Transformation in vitro of a nontumorigenic rat urothelial cell line by tumor necrosis factor-alpha. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[42] S. Kondo,et al. Penetration of keratinocyte‐derived cytokines into basement membrane , 1997, Journal of cellular physiology.
[43] S. Sasaki,et al. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism. , 1996, Gynecologic oncology.
[44] Y. Jin,et al. Studies on promoting activity of Taiwan betel quid ingredients in hamster buccal pouch carcinogenesis. , 1996, European journal of cancer. Part B, Oral oncology.
[45] C. Tsai,et al. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids. , 1995, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.
[46] M. Feldmann,et al. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. , 1995, European cytokine network.
[47] M. Feldmann,et al. Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease , 1995, Immunological reviews.
[48] M. Miller,et al. Induction of interleukin-6 in the epidermis of mice in response to tumor-promoting agents. , 1994, Carcinogenesis.
[49] J. Jeng,et al. Genotoxic and Non-genotoxic Effects of Betel Quid Ingredients on Oral Mucosal Fibroblasts in vitro , 1994, Journal of dental research.
[50] K. Ohta,et al. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. , 1993, Cancer research.
[51] R. Selvan,et al. Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after short-term exposure. , 1993, Immunopharmacology and immunotoxicology.
[52] A. Gori,et al. Acute-phase proteins and interleukin 6 serum level in head and neck cancer. , 1992, Archives of otolaryngology--head & neck surgery.
[53] J. Loré,et al. Surgery vs Chemotherapy-Reply , 1992 .
[54] R. Grafström,et al. Effects of areca nut on growth, differentiation and formation of DNA damage in cultured human buccal epithelial cells , 1992, International journal of cancer.
[55] S. J. Thomas,et al. Slaked lime and betel nut cancer in Papua New Guinea , 1992, The Lancet.
[56] E. Fuchs,et al. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] P. Balaram,et al. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer , 1992, Cancer.
[58] A. Gori,et al. Monocyte Tumor Necrosis Factor Production in Head and Neck Squamous Cell Carcinoma , 1992, The Laryngoscope.
[59] K. Malik,et al. Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells. , 1991, Molecular pharmacology.
[60] A. Ray,et al. Expression and function of interleukin‐6 in epithelial cells , 1991, Journal of cellular biochemistry.
[61] V. Dixit,et al. Keratinocytes as initiators of inflammation , 1991, The Lancet.
[62] E. A. Havell,et al. Tumor necrosis factor-independent IL-6 production during murine listeriosis. , 1991, Journal of immunology.
[63] T. Kupper. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.
[64] S. Weitzman,et al. Inflammation and cancer: role of phagocyte-generated oxidants in , 2011 .
[65] J. Rosenbloom,et al. Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.
[66] K Arvidson,et al. Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. , 1989, Cancer research.
[67] H. Stich,et al. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. , 1989, Mutation research.
[68] D. P. Murphy,et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[69] A. Zilberstein,et al. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[70] T. Elattar,et al. Cancer and the prostaglandins: a mini review on cancer research. , 1985, Journal of oral pathology.
[71] L. Marnett,et al. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. , 1981, Prostaglandins.
[72] R. Egan,et al. Prostaglandins, arachidonic acid, and inflammation. , 1980, Science.
[73] V. Devita,et al. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. , 1980, American Industrial Hygiene Association journal.
[74] R. L. Carter,et al. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.
[75] P. Grassi. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Vol. 11: Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics , 1977, British Journal of Cancer.
[76] I. Ishikawa,et al. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. , 2002, Journal of periodontal research.
[77] M. Kuo,et al. Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. , 2002, Oral oncology.
[78] H. Endo,et al. Induction of IL-6 via the EP3 subtype of prostaglandin E receptor in rat adjuvant-arthritic synovial cells , 2001, Inflammation Research.
[79] J. Shelhamer,et al. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[80] J. Shelhamer,et al. Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line , 2001 .
[81] D. Lopez,et al. Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha. , 2000, International journal of oncology.
[82] S. Kunkel,et al. Novel roles for chemokines and fibroblasts in interstitial fibrosis. , 1998, Kidney international.
[83] T. Hirano. Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.
[84] R. Sharan. Association of betel nut with carcinogenesis , 1996 .
[85] M. Selvakumaran,et al. Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure. , 1991, Immunopharmacology and immunotoxicology.
[86] J. Van Snick. Interleukin-6: an overview. , 1990, Annual review of immunology.
[87] J. Snick,et al. Interleukin-6: an overview. , 1990, Annual review of immunology.
[88] H. Bartsch,et al. Formation of reactive oxygen species and of 8-hydroxydeoxyguanosine in DNA in vitro with betel quid ingredients. , 1987, Chemico-biological interactions.